These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29729136)

  • 1. Overexpression and pre-treatment of recombinant human Secretory Leukocyte Protease Inhibitor (rhSLPI) reduces an in vitro ischemia/reperfusion injury in rat cardiac myoblast (H9c2) cell.
    Prompunt E; Nernpermpisooth N; Sanit J; Kumphune S
    Biomol Concepts; 2018 May; 9(1):17-32. PubMed ID: 29729136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial-Cell-Derived Human Secretory Leukocyte Protease Inhibitor (SLPI) Protects Cardiomyocytes against Ischemia/Reperfusion Injury.
    Kongpol K; Nernpermpisooth N; Prompunt E; Kumphune S
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31683729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an
    Pikwong F; Phutiyothin C; Chouyratchakarn W; Baipaywad P; Mongkolpathumrat P; Kumphune S
    Heliyon; 2023 Sep; 9(9):e20150. PubMed ID: 37809945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury.
    Prompunt E; Sanit J; Barrère-Lemaire S; Nargeot J; Noordali H; Madhani M; Kumphune S
    Exp Ther Med; 2018 Jun; 15(6):5231-5242. PubMed ID: 29904407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An
    Nernpermpisooth N; Prompunt E; Kumphune S
    Exp Ther Med; 2017 Dec; 14(6):5793-5800. PubMed ID: 29285123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury.
    Mongkolpathumrat P; Kijtawornrat A; Prompunt E; Panya A; Chattipakorn N; Barrère-Lemaire S; Kumphune S
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33924676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.
    Rosso M; Lapyckyj L; Amiano N; Besso MJ; Sánchez M; Chuluyan E; Vazquez-Levin MH
    Biol Cell; 2014 Sep; 106(9):308-22. PubMed ID: 25039920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of secretory leukocyte protease inhibitor (SLPI) on ischemia/reperfusion injury in cardiac transplantation.
    Schneeberger S; Hautz T; Wahl SM; Brandacher G; Sucher R; Steinmassl O; Steinmassl P; Wright CD; Obrist P; Werner ER; Mark W; Troppmair J; Margreiter R; Amberger A
    Am J Transplant; 2008 Apr; 8(4):773-82. PubMed ID: 18294346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells.
    Chen J; Mo H; Guo R; You Q; Huang R; Wu K
    Int J Mol Med; 2014 Mar; 33(3):605-12. PubMed ID: 24399619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes.
    Engelbrecht AM; Niesler C; Page C; Lochner A
    Basic Res Cardiol; 2004 Sep; 99(5):338-50. PubMed ID: 15309413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium lithospermate B improves myocardial function and prevents simulated ischemia/reperfusion injury-induced H9c2 cardiomyocytes apoptosis through Akt-dependent pathway.
    Quan W; Wu B; Bai Y; Zhang X; Yin J; Xi M; Guan Y; Shao Q; Chen Y; Wu Q; Wen A
    J Ethnopharmacol; 2014; 151(1):714-21. PubMed ID: 24296090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rutin from Lonicera japonica inhibits myocardial ischemia/reperfusion-induced apoptosis in vivo and protects H9c2 cells against hydrogen peroxide-mediated injury via ERK1/2 and PI3K/Akt signals in vitro.
    Jeong JJ; Ha YM; Jin YC; Lee EJ; Kim JS; Kim HJ; Seo HG; Lee JH; Kang SS; Kim YS; Chang KC
    Food Chem Toxicol; 2009 Jul; 47(7):1569-76. PubMed ID: 19362115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidative effect of luteolin pretreatment on simulated ischemia/reperfusion injury in cardiomyocyte and perfused rat heart.
    Zhang RQ; Li DY; Xu TD; Zhu SS; Pan HJ; Fang F; Wu X; Sun H
    Chin J Integr Med; 2017 Jul; 23(7):518-527. PubMed ID: 26956461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate and zinc provide anti-apoptotic protection against hypoxia/reoxygenation injury in H9c2 rat cardiac myoblast cells.
    Zeng X; Tan X
    Mol Med Rep; 2015 Aug; 12(2):1850-6. PubMed ID: 25872640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion.
    Mongkolpathumrat P; Kijtawornrat A; Suwan E; Unajak S; Panya A; Pusadee T; Kumphune S
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief exposure to carbon monoxide preconditions cardiomyogenic cells against apoptosis in ischemia-reperfusion.
    Kondo-Nakamura M; Shintani-Ishida K; Uemura K; Yoshida K
    Biochem Biophys Res Commun; 2010 Mar; 393(3):449-54. PubMed ID: 20152804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats.
    Sanit J; Prompunt E; Adulyaritthikul P; Nokkaew N; Mongkolpathumrat P; Kongpol K; Kijtawornrat A; Petchdee S; Barrère-Lemaire S; Kumphune S
    Exp Ther Med; 2019 Sep; 18(3):1701-1714. PubMed ID: 31410128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation.
    Yin Y; Guan Y; Duan J; Wei G; Zhu Y; Quan W; Guo C; Zhou D; Wang Y; Xi M; Wen A
    Eur J Pharmacol; 2013 Jan; 699(1-3):219-26. PubMed ID: 23200898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Protective Effect of INH2BP, a Novel PARP Inhibitor 5-Iodo-6-Amino-1,2-Benzopyrone, Against Hydrogen Peroxide-Induced Apoptosis Through ERK and p38 MAPK in H9c2 Cells.
    Back OC; Jang HS; Lee JS; Kim DE; Lee Y; Park ES; Kim IS
    Pharmacology; 2015; 96(5-6):259-70. PubMed ID: 26550832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
    Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
    Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.